GHK-Cu Research Overview: Copper Tripeptide in Preclinical Studies

Published March 2026 · White Market Peptides Research Library

Overview

GHK-Cu (glycyl-L-histidyl-L-lysine copper(II)) is a naturally occurring copper-binding tripeptide first isolated from human plasma by Loren Pickart in 1973. Originally identified as an activity in human albumin that caused aged liver tissue to synthesize proteins characteristic of younger tissue, GHK-Cu has since become one of the most extensively studied tripeptides in preclinical research, with investigations spanning dermal biology, gene expression modulation, extracellular matrix remodeling, and antioxidant defense systems.

The peptide exists naturally in human plasma, saliva, and urine, with plasma concentrations declining with age — an observation that has driven substantial research interest in its biological significance. At physiologically relevant concentrations (1–10 nanomolar), GHK-Cu has been shown to influence the expression of a remarkably large number of human genes, making it an important research tool for studying age-related changes in gene expression patterns.

The copper ion bound to the GHK tripeptide is essential for many of its observed biological activities, as copper serves as a cofactor for numerous enzymes involved in extracellular matrix synthesis, antioxidant defense, and cellular signaling.

Molecular Profile

CAS Number	49557-75-7
Molecular Formula	C14H24CuN6O4
Molecular Weight	403.93 g/mol
Sequence	Glycyl-L-histidyl-L-lysine + Cu²⁺
Alternative Names	Copper tripeptide-1, Copper peptide GHK, Glycyl-L-histidyl-L-lysine copper

Mechanism of Action

GHK-Cu operates through multiple interconnected mechanisms. Its copper-delivery function provides bioavailable copper to cells, supporting the activity of copper-dependent enzymes including lysyl oxidase (critical for collagen and elastin cross-linking), superoxide dismutase (antioxidant defense), and cytochrome c oxidase (mitochondrial electron transport). This copper-chaperone function alone influences numerous downstream biological processes.

At the gene expression level, studies using the Broad Institute Connectivity Map (CMap) have demonstrated that GHK modulates the expression of over 4,000 human genes at a concentration of 1 micromolar. This gene-modulatory activity affects pathways involved in extracellular matrix remodeling, antioxidant response, DNA repair, and inflammatory signaling (Pickart et al., 2015).

GHK-Cu also serves as a key modulator of matrix metalloproteinase (MMP) activity and their tissue inhibitors (TIMPs). Research has shown that GHK-Cu regulates both MMP and TIMP expression, influencing the balance between matrix degradation and synthesis — a critical process in tissue remodeling and wound repair (Siméon et al., 2000).

Key Areas of Investigation

Gene Expression Modulation

Broad Institute CMap analysis revealed that GHK influences the expression of genes across multiple functional categories. Notably, studies identified 84 cancer-related genes that were modulated by GHK, and at 1 micromolar concentration, the peptide suppressed 70% of genes found to be overexpressed in metastatic colon cancer datasets. These gene expression studies have positioned GHK-Cu as a research tool for studying large-scale transcriptomic changes (Pickart et al., 2014).

Extracellular Matrix Biology

Preclinical studies have demonstrated that GHK-Cu stimulates the synthesis of collagen types I and III, glycosaminoglycans, and decorin in fibroblast culture systems. Simultaneously, the peptide modulates matrix degradation through regulation of MMP-1, MMP-2, and their inhibitors, acting as a coordinator of ECM turnover rather than simply promoting synthesis or degradation (Siméon et al., 2000).

Wound Repair Models

Pickart et al. established through multiple studies that GHK-Cu accelerates wound closure and contraction in experimental models, improves the integration of transplanted tissue, and demonstrates anti-inflammatory properties. These studies were among the first to characterize GHK-Cu as a multifunctional tissue repair agent in preclinical settings.

Antioxidant Defense Systems

Research has demonstrated that GHK-Cu modulates the expression of numerous antioxidant genes, potentially reinforcing cellular defense against oxidative stress. Studies have proposed that GHK-Cu may influence copper homeostasis in a manner that supports superoxide dismutase activity and other copper-dependent antioxidant mechanisms (Pickart et al., 2015).

Dermal Biology Research

A substantial body of research has investigated GHK-Cu in the context of skin biology. Studies have examined its effects on fibroblast proliferation, collagen synthesis, and dermal remodeling in cell culture and skin explant models, contributing to the understanding of copper peptide biology in dermal tissue homeostasis (Pickart et al., 2012).

Key Published References

1. Pickart L, et al. “GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration.” Biomed Res Int. 2015;2015:648108. PMC: 4508379.
2. Pickart L, et al. “Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data.” Int J Mol Sci. 2018;19(7):1987. PMC: 6073405.
3. Pickart L, et al. “The Human Tripeptide GHK-Cu in Prevention of Oxidative Stress and Degenerative Conditions of Aging: Implications for Cognitive Health.” Oxid Med Cell Longev. 2012;2012:324832. PMID: 22666519.
4. Siméon A, et al. “Expression of Glycosaminoglycans and Small Proteoglycans in Wounds: Modulation by the Tripeptide-Copper Complex Glycyl-L-Histidyl-L-Lysine-Cu²⁺.” J Invest Dermatol. 2000;115(6):962–968. PMID: 11121125.
5. Pickart L, Margolina A. “GHK-Cu May Prevent Oxidative Stress in Skin by Regulating Copper and Modifying Expression of Numerous Antioxidant Genes.” Cosmetics. 2015;2(3):236–247.
6. Kang YA, et al. “Effects of GHK-Cu on MMP and TIMP Expression, Collagen and Elastin Production, and Facial Wrinkle Parameters.” J Cosmet Dermatol Sci Appl. 2009;7(4):166.

Product Availability

This compound is available for research purchase: GHK-Cu (100 mg)

Research Use Only. This product is sold exclusively for laboratory research use. It is not intended for human or animal consumption, clinical use, or veterinary applications, and is not intended to diagnose, treat, cure, or prevent any disease. All information presented here is a summary of published preclinical research and is provided for educational purposes only.